Symrise AG

EANS-News: Symrise AG again outperforms the market in 2009

- Sales grow by 3.2% - Normalized EBITDA slightly higher year-on-year - Significant increase in operating cash flow - Stable dividend of €0.50

@@start.t1@@--------------------------------------------------------------------------------   Corporate news transmitted by euro adhoc. The issuer/originator is solely   responsible for the content of this announcement. --------------------------------------------------------------------------------@@end@@

Financial Figures/Balance Sheet

Subtitle: - Sales grow by 3.2% - Normalized EBITDA slightly higher year-on-year - Significant increase in operating cash flow - Stable dividend of €0.50

Holzminden March 3, 2010 (euro adhoc) - Symrise AG enjoyed a robust increase in business in 2009 despite the challenging market environment. The company increased sales by 3.2 % at actual rates and by 2.7 % at local currency. Symrise thus again enjoyed stronger growth than the flavor and fragrances market, which stagnated in 2009. The EBITDA, adjusted for restructuring expenses, was slightly higher than in 2008. Symrise benefited from an increase in business during the second half of the year and the positive effects of the restructuring measures implemented over the course of the year.

Dr. Heinz-J├╝rgen Bertram, Chief Executive Officer of Symrise AG, said: "Symrise has demonstrated its resilience during the deepest recession in decades. We managed to maintain our above-average growth rate despite the difficult environment. Our strategic focus on large global customers, emerging markets and innovative products has paid off. At the same time we consequently adjusted to changing market conditions and made our operations leaner and more efficient. This contributed significantly to our ability to keep our normalized EBITDA margin at a high level. We want to share our business success with our shareholders and therefore intend to pay a stable dividend of EUR 0.50 per share."

Bertram added: "The market environment has improved in recent months, but continuously high raw material prices and the low level of consumer confidence still constitute challenges. We anticipate that Symrise will again exceed market growth and generate an EBITDA margin of at least 20 % in the current financial year. Our mid-term objective is to capitalize on our special strengths in dynamic regions and in innovative application areas to become the third-largest supplier in our market. We are confident that we can achieve this goal with our current strategy and under our own power."

Rapid growth in emerging markets In 2009, Symrise enjoyed a 3.2 % increase in Group sales from EUR 1,319.9 mil-lion to EUR 1,362.0 million. Sales at local currency rose by 2.7 %. Revenues generated in emerging markets grew disproportionately and increased by 4.5 % at local currency. Their share of the Group┬┤s total sales rose from 40 % in 2008 to 41 %.

The South American region grew particularly strong in 2009. Here Symrise in-creased sales by 12 % and by 17 % at local currency. The Asian/Pacific region contributed significantly to growth with an 8 % increase in sales (5 % at local currency). In North America Symrise revenues rose by 14 % (12 % at local currency), partly due to the acquisitions made in 2008. The EAME region, which was hit especially hard in the first half of the year by the weak economy and by destocking of customer inventories, returned to growth during the second half of the year. Sales in this region for the entire year declined by 4 % (3 % at local currency).

Improved earnings in second half of the year The Group┬┤s earnings benefited from an upswing in business in the second half of the year as well as from positive effects of the restructuring measures. Moreover, the Group was able to maintain the price increases implemented at the end of 2008 and beginning of 2009. Earnings suffered from a decline in demand due to the destocking of customers┬┤ inventories as well as from persistently high raw material costs, restructuring expenses and costs for the integration of acquisitions completed during the first half of the year. For the entire year Symrise had extraordinary restructuring expenses of EUR 19.9 million and final integration costs of EUR 2.4 million for acquisitions made in 2008.

At EUR 265.4 million, earnings before interest, taxes, depreciation and amortization (EBITDA) adjusted for restructuring expenses was slightly higher than the previous year┬┤s EBITDA of EUR 262.5 million. The normalized EBITDA margin of 19.5 % nearly reached the level of 19.9 % in 2008. The EBITDA amounted to EUR 245.6 million in 2009. This translated into an EBITDA margin of 18.0 %.

Net income declined from EUR 90.4 million to EUR 84.3 million. Symrise thus achieved earnings per share of EUR 0.71 following EUR 0.76 in 2008.

In view of the stable development of business in a difficult market environment, the executive board and the supervisory board of Symrise AG will propose to the Annual General Meeting to keep the dividend at the previous year┬┤s level of EUR 0.50 per share. This corresponds to a payout ratio of 70 % with respect to net income.

Significant increase in operating cash flow Effective working capital management contributed significantly to the consider-able increase in operating cash flow from EUR 153.1 million to EUR 225.7 million. Symrise used the cash inflow, among others, to further pay off financial liabilities. The company reduced net debt (including pension reserves) from EUR 833.6 million to EUR 773.4 million. The equity ratio improved to 36.4 % at the end of the year (Dec. 31, 2008: 34.3 %).

Above-average sales growth with core list customers Symrise again saw business with large global customers grow disproportion-ately. Sales with this strategically important customer group rose by 4.4 % in 2009. Large global customers thus accounted for 29 % of Group sales. With an increase of 9.1 % (9.0 % at local currency), the Flavor & Nutrition division in particular enjoyed a significant rise in revenues with major customers. Top customer sales growth in the Scent & Care division was lower due to the weaker demand in the fine fragrances segment and the luxury segment of personal care. Both divisions gained additional core list positions in 2009, thereby laying a solid basis for the further expansion of business with major global customers.

Scent & Care - slight sales increase in 2009 The Scent & Care division benefited from an increase in business during the second half of the year. Sales for the division rose by 1.6 % to EUR 682.3 million (previous year: EUR 671.8 million). Positive developments in the application area Household and in the mid-price segment of Personal Care more than compensated for the weak demand in Fine Fragrances and in the luxury segment of Personal Care. Oral Care also developed positively.

Like the Group as a whole, Scent & Care achieved dynamic growth in emerging markets with an increase of 5 % at local currency. The division boosted its sales in particular in South America, where even the luxury segment Fine Fra-grances grew in contrast to the trend in other regions. In North America Scent & Care benefited significantly from the acquisitions made in 2008. The emerging markets in the Asia/Pacific region also contributed to the growth in revenues. In EAME a surge in business during the second half of the year partially compen-sated for the slow development of business in the first half.

The Scent & Care division achieved an EBITDA of EUR 109.0 million (previous year: EUR 130.2 million) in 2009. The EBITDA margin amounted to 16.0 %. The normalized EBITDA was EUR 122.8 million, which translated into an EBITDA margin of 18.0 %.

Flavor & Nutrition - EBITDA above previous year┬┤s figure The Flavor & Nutrition division increased revenues from EUR 648.1 million to EUR 679.7 million in the 2009 financial year. This represents a 5 % increase at local currency. Following the destocking of customer inventories in the first half of the year, business improved significantly during the second half of the year.

Growth was especially strong in the emerging markets of South America and in the Asia/Pacific region. Flavor & Nutrition┬┤s sales in South America grew by 21 % at local currency. In North America the division outperformed the market, partially driven by acquisitions. Business in the EAME region recovered during the second half of the year following the destocking of customer inventories in the first half of the year.

The Flavor & Nutrition division made an important strategic move in the fourth quarter with the establishment of the new global Consumer Health business unit. Consumer Health focuses on the dynamic segments of functional ingredients for nutritional supplements and flavor solutions for the pharmaceutical industry. Symrise builds on its particular strength in innovation and on its techno-logical expertise to systematically develop a new business area.

Despite persistently high raw material costs and the unfavorable business development in the first half of the year, Flavor & Nutrition increased its EBITDA to EUR 136.6 million in 2009 over EUR 132.3 million for the prior year. The division thereby achieved an EBITDA margin of 20.1 %. Adjusted for restructuring expenses, the EBITDA rose by 7.8 % to EUR 142.6 million. This corresponds to a normalized EBITDA margin of 21.0 %.

Key Figures Group

@@start.t2@@in  EUR million                            2008          2009  Change in %    Change in % (LC)
Sales                                        1,319.9      1,362.0         3.2                  2.7
EBITDA                                         262.5         265.4            1                    1
EBITDA margin┬╣ in %                      19.9          19.5
EBIT                                            187.0         163.0         -13                 -13
EBIT margin in %                          14.2          12.0
Net income                                    90.4          84.3          -7
Earnings per share in EUR            0.76          0.71          -7
Dividend per share in EUR            0.50          0.50┬│          0
Balance Sheet (31.12.)            1,890.6      1,895.2            0
Equity ratio (31.12.)                  34.3          36.4
Capital expenditures                    52.5          56.7
Net debt (incl. pension
provisions)/EBITDA
(31.12.) ratio                                3.2            3.1
Operating Cashflow                      153.1         225.7            47
Employees (31.12.) FTE┬▓              5,097         4,954            -3

Scent & Care
Sales                                          671.8            682.3        1.6                1.0
EBITDA┬╣                                        130.2            122.8        -6                  -7
EBITDA margin┬╣ in%                        19.4              18.0

Flavor & Nutrition
Sales                                          648.1            679.7        4.9                 4.5
EBITDA┬╣                                        132.3            142.6         8                  8
EBITDA margin┬╣ in%                        20.4              21.0@@end@@

┬╣ Figure for 2009 adjusted for restructuring costs ┬▓ Not including apprentices and trainees, FTE = Full Time Equivalent ┬│ Proposal

About Symrise

Symrise is a global supplier of fragrances and flavorings while also manufacturing raw materials and active ingredients for the perfume, cosmetics and food industries.

Its sales of EUR 1.36 billion in 2009 place the company among the top four in the international flavors and fragrances market. Headquartered in Holzminden, Germany, Symrise is represented in over 35 countries in Europe, Asia, the United States and South America.

Used by manufacturers of perfumes, cosmetics and foods, our products are an inseparable part of daily life. At Symrise we combine an awareness of consumer trends with cutting-edge technologies, focusing on innovative fashion and lifestyle products that have additional practical value for the consumer. Symrise - always inspiring more┬ů www.symrise.com

Press Contact:                         Investor Contact:
Bernhard Kott                          Dr. Andrea Rolvering
Tel. +49 (0)5531 90-1721         Tel. +49 (0)69 75 93 75 94
bernhard.kott@symrise.com        andrea.rolvering@symrise.com

@@start.t3@@end of announcement                                                 euro adhoc
--------------------------------------------------------------------------------@@end@@

ots Originaltext: Symrise AG
Im Internet recherchierbar: http://www.presseportal.ch

Further inquiry note:
Carolin Amann
FD
+49-69-92037-132

Branche: Chemicals
ISIN:      DE000SYM9999
WKN:        SYM999
Index:    MDAX
B├Ârsen:  Frankfurt / regulated dealing/prime standard
              Berlin / free trade
              Hamburg / free trade
              Stuttgart / free trade
              D├╝sseldorf / free trade
              Hannover / free trade
              M├╝nchen / free trade



Weitere Meldungen: Symrise AG

Das könnte Sie auch interessieren: